title: Assessment of the implementation of the infectious diseases screening programmes among pregnant women in the Lesser Poland region and comparison with similar programmes conducted in other European Union countries.
abstract: The aim of the study was to assess the level of implementation of recommendations of the Ministry of Health regarding infectious disease screening during pregnancy.
  
  
  
  The study included 477 patients who were admitted to the delivery room between December 2015 and February 2016. Data on screening test results were collected based on medical records covering the period before the admission.
  
  
  
  The Human Immunodeficiency Virus (HIV) screening was conducted in 410 (86%). 460 (96%) of patients were screened for Hepatitis B Virus (HBV) and 427 (89.5%) for Hepatitis C Virus (HCV). Syphilis screening covered 465 (97.5%) of patients. Immunoglobulin M (IgM) titer against Rubella Virus (RV) was assessed in 218 (45%) patients and immunoglobulin G (IgG) in 319 (66.9%). Screening for Toxoplasma gondii based on assessment of IgM titer was conducted in 440 (92%) patients while IgG titter was assessed in 413 (86.6%). 343 (71.9%) patients had obtained vaginal swabs for Group B Streptococci (GBS) while the anal swabs were taken only from 268 (56.2%) patients.
  
  
  
  Coverage of screening for syphilis and HBV was similar to the countries with highest prevalence of conducting such screening, on the other hand RV screening place as among countries with lowest prevalence. There is an increasing trend in conducting HIV screening. Screening for HCV and toxoplasmosis is at satisfactory level and Poland is one of a few European countries offering such screening. The screening for GBS is insufficient which result in excessive use of intrapartum antibiotic prophylaxis.
authors.affiliation: Department of Obstetrics and Gynecology, Jagiellonian University Medical College in Krakow, Poland. malgorzata.radon@gmail.com.
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Radoń-Pokracka
authors.forename: Maciej
authors.initials: M
authors.lastname: Piasecki
authors.forename: Alicja
authors.initials: A
authors.lastname: Lachowska
authors.forename: Sebastian
authors.initials: S
authors.lastname: Baczkowski
authors.forename: Joanna
authors.initials: J
authors.lastname: Spaczyńska
authors.forename: Magdalena
authors.initials: M
authors.lastname: Górecka
authors.forename: Magdalena
authors.initials: M
authors.lastname: Nowak
authors.forename: Hubert
authors.initials: H
authors.lastname: Huras
mesh_terms: D000328:Adult; D003141:Communicable Diseases / Q000175:diagnosis* / Q000276:immunology; D005062:European Union; D005260:Female; D015658:HIV Infections / Q000175:diagnosis; D006509:Hepatitis B / Q000175:diagnosis / Q000276:immunology; D006526:Hepatitis C / Q000175:diagnosis / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D007075:Immunoglobulin M / Q000276:immunology; D008403:Mass Screening / Q000706:statistics & numerical data*; D011044:Poland; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000175:diagnosis* / Q000276:immunology; D011295:Prenatal Care / Q000706:statistics & numerical data*; D012409:Rubella / Q000175:diagnosis / Q000276:immunology; D012412:Rubella virus / Q000276:immunology; D012698:Serologic Tests; D013290:Streptococcal Infections / Q000175:diagnosis; D013292:Streptococcus agalactiae; D013587:Syphilis / Q000175:diagnosis; D014122:Toxoplasma / Q000276:immunology; D014123:Toxoplasmosis / Q000175:diagnosis / Q000276:immunology
chemical_list: D007074:Immunoglobulin G; D007075:Immunoglobulin M
keywords: infectious diseases in pregnancy; prenatal care; screening programmes